356 related articles for article (PubMed ID: 23352605)
1. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
[TBL] [Abstract][Full Text] [Related]
2. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.
Kim EM; Manzar G; Zavazava N
Immunology; 2017 Jun; 151(2):191-197. PubMed ID: 28185259
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of induced pluripotent stem cells.
Zhao T; Zhang ZN; Rong Z; Xu Y
Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
[TBL] [Abstract][Full Text] [Related]
5. Efficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells.
Anchan R; Gerami-Naini B; Lindsey JS; Ho JW; Kiezun A; Lipskind S; Ng N; LiCausi JA; Kim CS; Brezina P; Tuschl T; Maas R; Kearns WG; Williams Z
PLoS One; 2015; 10(3):e0119275. PubMed ID: 25751620
[TBL] [Abstract][Full Text] [Related]
6. Cells derived from iPSC can be immunogenic - yes or no?
Cao J; Li X; Lu X; Zhang C; Yu H; Zhao T
Protein Cell; 2014 Jan; 5(1):1-3. PubMed ID: 24474200
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
[TBL] [Abstract][Full Text] [Related]
8. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium.
Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C
PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453
[TBL] [Abstract][Full Text] [Related]
10. No immunogenicity of IPS cells in syngeneic host studied by in vivo injection and 3D scaffold experiments.
Thanasegaran S; Cheng Z; Ito S; Nishio N; Isobe K
Biomed Res Int; 2013; 2013():378207. PubMed ID: 23691499
[TBL] [Abstract][Full Text] [Related]
11. [At Home among Strangers: Is It Possible to Create Hypoimmunogenic Pluripotent Stem Cell Lines?].
Bogomiakova ME; Eremeev AV; Lagarkova MA
Mol Biol (Mosk); 2019; 53(5):725-740. PubMed ID: 31661474
[TBL] [Abstract][Full Text] [Related]
12. Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation.
Yoshida S; Miyagawa S; Toyofuku T; Fukushima S; Kawamura T; Kawamura A; Kashiyama N; Nakamura Y; Toda K; Sawa Y
Sci Rep; 2020 Mar; 10(1):4593. PubMed ID: 32165680
[TBL] [Abstract][Full Text] [Related]
13. Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs.
Strnadel J; Carromeu C; Bardy C; Navarro M; Platoshyn O; Glud AN; Marsala S; Kafka J; Miyanohara A; Kato T; Tadokoro T; Hefferan MP; Kamizato K; Yoshizumi T; Juhas S; Juhasova J; Ho CS; Kheradmand T; Chen P; Bohaciakova D; Hruska-Plochan M; Todd AJ; Driscoll SP; Glenn TD; Pfaff SL; Klima J; Ciacci J; Curtis E; Gage FH; Bui J; Yamada K; Muotri AR; Marsala M
Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743351
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives.
Bogomiakova ME; Bogomazova AN; Lagarkova MA
Biochemistry (Mosc); 2024 May; 89(5):799-816. PubMed ID: 38880643
[TBL] [Abstract][Full Text] [Related]
15. Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells.
Zhao T; Zhang ZN; Westenskow PD; Todorova D; Hu Z; Lin T; Rong Z; Kim J; He J; Wang M; Clegg DO; Yang YG; Zhang K; Friedlander M; Xu Y
Cell Stem Cell; 2015 Sep; 17(3):353-9. PubMed ID: 26299572
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
[TBL] [Abstract][Full Text] [Related]
17. Control of Immune Response to Allogeneic Embryonic Stem Cells by CD3 Antibody-Mediated Operational Tolerance Induction.
Calderon D; Prot M; You S; Marquet C; Bellamy V; Bruneval P; Valette F; de Almeida P; Wu JC; Pucéat M; Menasché P; Chatenoud L
Am J Transplant; 2016 Feb; 16(2):454-67. PubMed ID: 26492394
[TBL] [Abstract][Full Text] [Related]
18. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.
Swijnenburg RJ; Tanaka M; Vogel H; Baker J; Kofidis T; Gunawan F; Lebl DR; Caffarelli AD; de Bruin JL; Fedoseyeva EV; Robbins RC
Circulation; 2005 Aug; 112(9 Suppl):I166-72. PubMed ID: 16159810
[TBL] [Abstract][Full Text] [Related]
19. Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells.
Wang X; Qin J; Zhao RC; Zenke M
PLoS One; 2014; 9(8):e106110. PubMed ID: 25166861
[TBL] [Abstract][Full Text] [Related]
20. Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance.
de Almeida PE; Meyer EH; Kooreman NG; Diecke S; Dey D; Sanchez-Freire V; Hu S; Ebert A; Odegaard J; Mordwinkin NM; Brouwer TP; Lo D; Montoro DT; Longaker MT; Negrin RS; Wu JC
Nat Commun; 2014 May; 5():3903. PubMed ID: 24875164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
